Topics

Omixon’s OmniType is Now Available Under Early Access

03:51 EST 3 Feb 2020 | Bio-Medicine

BUDAPEST, Hungary and CAMBRIDGE, Mass. (PRWEB) February 03, 2020 Global molecular diagnostics company Omixon, headquartered in Budapest with US offices in Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype HLA is available through an Early Access...

Original Article: Omixon’s OmniType is Now Available Under Early Access

NEXT ARTICLE

More From BioPortfolio on "Omixon’s OmniType is Now Available Under Early Access"

Quick Search

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...